EU MDR transition deadlines have been extended several times — which has caused significant confusion among manufacturers. Many companies believe they have more time than they actually do. This guide cuts through the confusion and gives you the exact dates you need to plan around in 2026, 2027 and 2028.
The 28 May 2026 deadline is the most immediately urgent for most non-EU manufacturers. This is the date when EUDAMED registration becomes fully mandatory for all economic operators — manufacturers, EU Authorized Representatives, importers and distributors.
After this date, any company without a valid EUDAMED registration and SRN (Single Registration Number) faces immediate market suspension by Competent Authorities across all 27 EU member states. There is no grace period and no warnings — products are simply removed from sale.
The registration process takes 4-8 weeks minimum. If you have not started yet, you need to act immediately to meet the May 2026 deadline comfortably. Read our complete EUDAMED registration guide or contact us for a free assessment.
Devices that were CE marked under the old Medical Device Directive (MDD) or Active Implantable Medical Device Directive (AIMDD) have been given transition periods to move to EU MDR certification. These transition deadlines are hard deadlines — there are no further extensions expected.
This is the most critical transition deadline. Class III devices — including all implantable devices, devices incorporating medicinal substances, and devices using tissues of human or animal origin — must have full EU MDR Notified Body certification by 31 December 2027. Given that Notified Body review currently takes 13-18 months on average, manufacturers who have not started their MDR submission process by mid-2026 are at serious risk of missing this deadline.
Other Class IIb devices, all Class IIa devices (such as surgical instruments, contact lenses, ultrasound equipment), and Class I sterile and measuring devices have until 31 December 2028. This sounds like a long time — but given Notified Body backlogs, manufacturers should be submitting technical documentation now, not waiting.
One of the most underappreciated risks in the EU MDR transition is the Notified Body capacity crisis. There are fewer Notified Bodies designated under EU MDR than under the old MDD, and their review capacity is significantly stretched. Average review times for a successful MDR certification are currently 13-18 months — meaning if you submit in mid-2026, you may not receive certification until late 2027 or early 2028.
For Class III devices with a December 2027 deadline, this leaves almost no margin for error. Any request for additional information from the Notified Body — which is extremely common — can push the timeline past the deadline.
Missing an EU MDR deadline is not a theoretical risk — Competent Authorities have the power to remove non-compliant devices from the market immediately. The consequences include market suspension, product recalls, financial penalties that vary by member state, and reputational damage that can be difficult to recover from in a relationship-driven market like medical devices.
NordMDR AB provides EU Authorized Representative services, EUDAMED registration, gap analysis and technical documentation support to help non-EU manufacturers meet every EU MDR deadline on time. We onboard new clients within 5 business days and provide clear timelines and fixed fees from day one.
Free compliance assessment — we tell you exactly where you stand against every deadline and what you need to do. No obligation.
Get Free Deadline Assessment →